台湾 - 中文 - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

尚唯國際貿易有限公司 台南巿文南路１０５巷５號 (69856424) - l-isoleucine;;l-valine;;glycine (eq to aminoacetic acid)(eq to glycocoll);;l-leucine;;histidine l- hcl monohydrate;;lysine l- hcl ( eq to l-lysine hcl);;l-arginine;;inositol (meso-inositol);;asparatate zine-bis-hydrogen dl- monohydrate;;l-methionine;;ornithine l- aspartate l-;;malic acid l-;;l-phenylalanine;;l-threonine;;glutamic acid l-;;l-proline;;l-tryptophan;;sodium carbonate monohydrate;;l-alanine;;sorbitol;;xylitol;;sodium bisulfate;;thiamine hydrochloride;;niacinamide (nicotinamide);;riboflavin phosphate sodium;;panthenol;;pyridoxine hcl - 注射劑 - sodium bisulfate (4004000400) 0.180gm; xylitol (4020001900) 50.00gm; l-alanine (4020100202) 6.00gm; l-arginine (4020100302) 5.60gm; asparatate zine-bis-hydrogen dl- monohydrate (4020100465) 0.02gm; glutamic acid l- (4020100702) 3.60gm; histidine l- hcl monohydrate (4020100922) 2.04gm; l-isoleucine (4020101002) 2.40gm; l-leucine (4020101202) 3.50gm; lysine l- hcl ( eq to l-lysine hcl) (4020101312) 3.50gm; l-methionine (4020101502) 3.00gm; ornithine l- aspartate l- (4020101622) 1.40gm; l-phenylalanine (4020101702) 3.30gm; l-proline (4020101802) 6.50gm; l-threonine (4020102002) 1.90gm; l-tryptophan (4020102102) 0.90gm; l-valine (4020102302) 2.75gm; glycine (eq to aminoacetic acid)(eq to glycocoll) (4020102400) 4.70gm; panthenol (8416000700) 0.030gm; niacinamide (nicotinamide) (8810000300) 0.060gm; thiamine hydrochloride (8810100900) 0.020gm; riboflavin phosphate sodium (8810200700) 0.010gm; pyridoxine hcl (8810600300) 0.040gm; inositol (meso-inositol) (8813000100) 0.50gm; malic acid l- (9600017802) 2.05gm; sodium carbonate monohydrate (9600027560) 2.48gm; sorbitol (9600029600) 100.00gm - 不能攝取適當食物之患者之補助治療劑、蛋白質之消化吸收機能及合成利用障礙、嚴重創傷、火傷、骨折時蛋白質之補給、蛋白質維生素Ｂ攝取減少之營養失調症

台湾 - 中文 - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

尚唯國際貿易有限公司 台南巿文南路１０５巷５號 (69856424) - l-isoleucine;;l-leucine;;l-methionine;;lysine l- hcl ( eq to l-lysine hcl);;histidine l- hcl monohydrate;;l-phenylalanine;;l-threonine;;l-valine;;l-tryptophan;;l-arginine;;glutamic acid l-;;ornithine l- aspartate l-;;aspartate zinc-bis hydrogen;;l-proline;;l-alanine;;glycine (eq to aminoacetic acid)(eq to glycocoll);;inositol (meso-inositol);;malic acid l-;;sodium chloride;;sodium acetate;;sodium carbonate monohydrate;;potassium carbonate;;potassium chloride;;magnesium chloride;;sorbitol;;xylitol;;sodium bisulfate;;thiamine hydrochloride;;niacinamide (nicotinamide);;riboflavin phosphate sodium;;panthenol;;pyridoxine hcl - 注射劑 - sodium bisulfate (4004000400) 0.080gm; potassium carbonate (4008000200) 1.382gm; sodium acetate (4008000600) 2.041gm; magnesium chloride (4012001500) 0.610gm; potassium chloride (4012001800) 0.210gm; sodium chloride (4012002100) 1.929gm; xylitol (4020001900) 17.500gm; l-alanine (4020100202) 4.56gm; l-arginine (4020100302) 3.54gm; aspartate zinc-bis hydrogen (4020100460) 0.02gm; glutamic acid l- (4020100702) 2.76gm; histidine l- hcl monohydrate (4020100922) 0.96gm; l-isoleucine (4020101002) 1.14gm; l-leucine (4020101202) 1.62gm; lysine l- hcl ( eq to l-lysine hcl) (4020101312) 1.68gm; l-methionine (4020101502) 1.44gm; ornithine l- aspartate l- (4020101622) 0.84gm; l-phenylalanine (4020101702) 1.62gm; l-proline (4020101802) 3.90gm; l-threonine (4020102002) 0.90gm; l-tryptophan (4020102102) 0.42gm; l-valine (4020102302) 1.32gm; glycine (eq to aminoacetic acid)(eq to glycocoll) (4020102400) 3.90gm; panthenol (8416000700) 0.030gm; niacinamide (nicotinamide) (8810000300) 0.060gm; thiamine hydrochloride (8810100900) 0.020gm; riboflavin phosphate sodium (8810200700) 0.010gm; pyridoxine hcl (8810600300) 0.040gm; inositol (meso-inositol) (8813000100) 0.50gm; malic acid l- (9600017802) 2.681gm; sodium carbonate monohydrate (9600027560) 1.364gm; sorbitol (9600029600) 32.500gm - 不能攝取適當食物之患者之補助治療劑、蛋白質之消化吸收機能及合成利用障礙、嚴重創傷、火傷、骨折時蛋白質之補給蛋白質、維生素Ｂ攝取減少之營養失調症

台湾 - 中文 - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

富富企業股份有限公司 台北巿民生東路一段４２號四樓之１ (04264685) - l-isoleucine;;lysine l- (hcl);;l-phenylalanine;;l-valine;;l-arginine;;l-alanine;;l-proline;;ornithine l- aspartate l-;;sodium acetate trihydrate (eq to sodium acetate 3h2o );;potassium chloride;;l-tryptophan;;l-leucine;;l-methionine;;l-threonine;;l-histidine;;glutamic acid l-;;glycine (eq to aminoacetic acid)(eq to glycocoll);;l-serine;;malic acid l-;;sorbitol;;sodium hydroxide;;magnesium acetate tetrahydrate - 注射劑 - sodium acetate trihydrate (eq to sodium acetate 3h2o ) (4008000670) 2.722mg; magnesium acetate tetrahydrate (4012001450) 0.858mg; potassium chloride (4012001800) 2.088mg; l-alanine (4020100202) 4.030mg; l-arginine (4020100302) 3.700mg; glutamic acid l- (4020100702) 0.800mg; l-histidine (4020100902) 0.890mg; l-isoleucine (4020101002) 1.530mg; l-leucine (4020101202) 2.330mg; l-methionine (4020101502) 1.930mg; ornithine l- aspartate l- (4020101622) 0.800mg; l-phenylalanine (4020101702) 2.770mg; l-proline (4020101802) 4.830mg; l-serine (4020101902) 0.970mg; l-threonine (4020102002) 1.290mg; l-tryptophan (4020102102) 0.560gm; l-valine (4020102302) 1.800mg; glycine (eq to aminoacetic acid)(eq to glycocoll) (4020102400) 1.770mg; lysine l- (hcl) (4020191312) (2.740mg) 2.19mg; malic acid l- (9600017802) 1.850mg; sodium hydroxide (9600028200) 0.600mg; sorbitol (9600029600) 125.000mg - 手術前後之營養補給、低蛋白血症、消化道潰瘍、營養障礙之補給

台湾 - 中文 - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

尚唯國際貿易有限公司 台南巿文南路１０５巷５號 (69856424) - l-arginine;;l-proline;;thiamine hydrochloride;;l-threonine;;l-valine;;pyridoxine hcl;;glutamic acid l-;;l-leucine;;cystine l-;;sorbitol;;sodium acetate;;lysine l- hcl ( eq to l-lysine hcl);;sodium carbonate monohydrate;;l-alanine;;xylitol;;l-isoleucine;;panthenol;;l-methionine;;l-phenylalanine;;niacinamide (nicotinamide);;sodium bisulfate;;malic acid l-;;ornithine l- aspartate l-;;l-tryptophan;;l-glycine;;inositol (meso-inositol);;riboflavin phosphate sodium;;potassium carbonate;;l-tyrosine;;magnesium chloride;;aspartate zinc-bis hydrogen dl- - 注射劑 - sodium bisulfate (4004000400) 0.210gm; potassium carbonate (4008000200) 1.73gm; sodium acetate (4008000600) 1.36gm; magnesium chloride (4012001500) 1.02gm; xylitol (4020001900) 50.00gm; l-alanine (4020100202) 11.60gm; l-arginine (4020100302) 10.00gm; aspartate zinc-bis hydrogen dl- (4020100463) 0.02gm; cystine l- (4020100602) 0.080gm; glutamic acid l- (4020100702) 7.20gm; l-isoleucine (4020101002) 4.80gm; l-leucine (4020101202) 7.10gm; lysine l- hcl ( eq to l-lysine hcl) (4020101312) 7.00gm; l-methionine (4020101502) 6.80gm; ornithine l- aspartate l- (4020101622) 2.50gm; l-phenylalanine (4020101702) 6.00gm; l-proline (4020101802) 12.80gm; l-threonine (4020102002) 3.85gm; l-tryptophan (4020102102) 1.75gm; l-tyrosine (4020102202) 0.60gm; l-valine (4020102302) 5.50gm; l-glycine (4020102401) 10.00gm; panthenol (8416000700) 0.030gm; niacinamide (nicotinamide) (8810000300) 0.060gm; thiamine hydrochloride (8810100900) 0.020gm; riboflavin phosphate sodium (8810200700) 0.010gm; pyridoxine hcl (8810600300) 0.040gm; inositol (meso-inositol) (8813000100) 0.50gm; malic acid l- (9600017802) 2.05gm; sodium carbonate monohydrate (9600027560) 1.86gm; sorbitol (9600029600) 100.00gm - 不能攝取適當食物之患者之補助治療劑、蛋白質之消化吸收機能及合成利用障礙、嚴重創傷、火傷、骨折時蛋白維生素Ｂ攝取減少之營養失調症

台湾 - 中文 - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

尚唯國際貿易有限公司 台南巿文南路１０５巷５號 (69856424) - arginine hcl l-;;panthenol;;cyanocobalamin (vit b12);;malic acid dl-;;riboflavin phosphate sodium;;l-arginine;;niacinamide (nicotinamide);;xylitol;;biotin;;magnesium sulfate;;potassium carbonate;;ornithine l- aspartate l-;;pyridoxine hcl;;edetate disodium dihydrate (eq to disodium edetate dihydrate);;glutamic acid l-;;sorbitol;;sodium carbonate monohydrate;;sodium bisulfate;;edetate disodium dihydrate (eq to disodium edetate dihydrate);;thiamine hydrochloride - 注射劑 - sodium bisulfate (4004000400) 0.010gm; potassium carbonate (4008000200) 1.244gm; xylitol (4020001900) 25.000gm; l-arginine (4020100302) 10.0gm; arginine hcl l- (4020100312) 6.1gm; glutamic acid l- (4020100702) 2.000gm; ornithine l- aspartate l- (4020101622) 8.0gm; magnesium sulfate (5612001500) 0.863gm; edetate disodium dihydrate (eq to disodium edetate dihydrate) (6400000315) 0.020gm; edetate disodium dihydrate (eq to disodium edetate dihydrate) (6400000315) 0.0001gm; panthenol (8416000700) 0.0500gm; biotin (8810000100) 0.0020gm; niacinamide (nicotinamide) (8810000300) 0.100gm; thiamine hydrochloride (8810100900) 0.010gm; riboflavin phosphate sodium (8810200700) 0.020gm; pyridoxine hcl (8810600300) 0.100gm; cyanocobalamin (vit b12) (8811200300) 0.0025gm; malic acid dl- (9600017803) 6.600gm; sodium carbonate monohydrate (9600027560) 2.670gm; sorbitol (9600029600) 50.000gm - 降低血中氨之濃度、肝臟疾患

台湾 - 中文 - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

台灣瑞迪博士有限公司 臺北市信義區信義路5段7號57樓之1(5727室) (42992299) - pemetrexed disodium heptahydrate - 凍晶注射劑 - pemetrexed disodium heptahydrate (1004002410) pemetrexed disodium (eq. to pemetrexed.....100mg)mg - pemetrexed - 1.併用cisplatin是治療局部晚期或轉移性非小細胞肺癌(顯著鱗狀細胞組織型除外)之第一線化療用藥。2.pemetrexed單一藥物是局部晚期或轉移性非小細胞肺癌(顯著鱗狀細胞組織型除外)病人接受4個週期含鉑藥物的第一線化療後疾病並未惡化之維持療法。3.單一藥物是治療局部晚期或轉移性非小細胞肺癌(顯著鱗狀細胞組織型除外)之第二線治療用藥。4.與cisplatin併用於治療惡性助膜間質細胞瘤。

台湾 - 中文 - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

台灣瑞迪博士有限公司 臺北市信義區信義路5段7號57樓之1(5727室) (42992299) - pemetrexed disodium heptahydrate - 凍晶注射劑 - pemetrexed disodium heptahydrate (1004002410) pemetrexed disodium (eq. to pemetrexed.....500mg)mg - pemetrexed - 1.併用cisplatin是治療局部晚期或轉移性非小細胞肺癌(顯著鱗狀細胞組織型除外)之第一線化療用藥。2.pemetrexed單一藥物是局部晚期或轉移性非小細胞肺癌(顯著鱗狀細胞組織型除外)病人接受4個週期含鉑藥物的第一線化療後疾病並未惡化之維持療法。3.單一藥物是治療局部晚期或轉移性非小細胞肺癌(顯著鱗狀細胞組織型除外)之第二線治療用藥。4.與cisplatin併用於治療惡性助膜間質細胞瘤。

台湾 - 中文 - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

永信藥品工業股份有限公司 台中市大甲區頂店里中山路一段1191號 (56065601) - pemetrexed disodium heptahydrate;;pemetrexed disodium heptahydrate - 凍晶注射劑 - pemetrexed disodium heptahydrate (1004002410) (eq. to pemetrexed.....100mg)mg; pemetrexed disodium heptahydrate (1004002410) (eq. to pemetrexed.....500mg)mg - pemetrexed - 1.併用cisplatin是治療局部晚期或轉移性非小細胞肺癌（顯著鱗狀細胞組織型除外）之第一線化療用藥。2.單一藥物是局部晚期或轉移性非小細胞肺癌（顯著鱗狀細胞組織型除外）病人接受4個週期含鉑藥物的第一線化療後疾病並未惡化之維持療法。3.單一藥物是治療局部晚期或轉移性非小細胞肺癌（顯著鱗狀細胞組織型除外）之第二線治療用藥。4.與cisplatin併用於治療惡性肋膜間質細胞瘤。

台湾 - 中文 - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

臺灣必治妥施貴寶股份有限公司 台北市松山區健康路156號4樓、5樓 (11922609) - warfarin sodium crystalline - 錠劑 - warfarin sodium crystalline (2012401021) 1mg - warfarin - 1.預防及/或治療靜脈栓塞症及其相關疾病，以及肺栓塞。2.預防或治療因心房纖維顫動及/或更換心臟瓣膜引起之血栓性栓塞症。

台湾 - 中文 - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

優良化學製藥股份有限公司 新竹縣湖口鄉中興村光復路10號 (44988454) - warfarin sodium - 錠劑 - warfarin sodium (2012401020) mg - warfarin - 1.預防及/或治療靜脈栓塞症及其相關疾病，以及肺栓塞。2.預防或治療因心房纖維顫動及/或更換心臟瓣膜引起之血栓性栓塞症。